Deaths from pregnancy complications have become more prevalent in Mississippi, and racial disparities in the health of those who give birth have widened in recent years, according to a report released Thursday by the state's ...
Jan 27, 2023
0
9
Developmental disorders, disabilities, and delays are common outcomes for infants with complex congenital heart disease. Targeting early factors influencing these conditions after birth and during neonatal hospitalization ...
Jan 26, 2023
0
2
The US Food and Drug Administration's approval process for a controversial drug used to treat Alzheimer's was "rife with irregularities," a congressional report said Thursday.
Dec 29, 2022
0
20
In U.S. states with more restrictive abortion policies, rates of pregnant women, new mothers and infants dying were higher, a new report finds.
Dec 14, 2022
0
0
People who have sought help for drugs and alcohol should be actively involved when developing new services according to new research from the University of Aberdeen.
Nov 29, 2022
0
2
Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay ...
Nov 9, 2022
0
3
The latest government study on teen vaping suggests there's been little progress in keeping e-cigarettes out of the hands of kids.
Oct 6, 2022
0
4
In the fall of 2018, cancer researcher Corrie Painter began presenting some intriguing early results from a new study on a rare and deadly cancer known as angiosarcoma. She and her fellow scientists hoped that by sharing ...
Sep 14, 2022
0
8
A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.
Sep 7, 2022
0
4
Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...
Sep 2, 2022
0
2
